NCT06739759Recruiting
Ovarian Hyperstimulation Syndrome Prevention
Prophylaxis Against Ovarian Hyperstimulation Syndrome in PCOS Women
Source: ClinicalTrials.gov · Last updated 18 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Ovarian hyperstimulation is a very hazardous complication of ICSI
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 23 Oct 2024
- Start date
- 17 Nov 2024
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Aljazeera Hospital
- NCT number
- NCT06739759
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 17 Nov 2024 to the primary completion date, 30 Jun 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Women who donnot have PCOS
Who the study is looking for
- Women with PCOS coming for ICSI
Age in the registry: 19 years to 42 years · Sex: Female · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Algazeerah Coordinator of this site? Confirm its status | Giza | Egypt | Recruiting |
| Aljazeerah hospital Coordinator of this site? Confirm its status | Giza | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.